These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 17408209

  • 1. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.
    Hathout RM, Mansour S, Mortada ND, Guinedi AS.
    AAPS PharmSciTech; 2007 Jan 05; 8(1):1. PubMed ID: 17408209
    [Abstract] [Full Text] [Related]

  • 2. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS, Mortada ND, Mansour S, Hathout RM.
    Int J Pharm; 2005 Dec 08; 306(1-2):71-82. PubMed ID: 16263229
    [Abstract] [Full Text] [Related]

  • 3. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
    Aggarwal D, Garg A, Kaur IP.
    J Pharm Pharmacol; 2004 Dec 08; 56(12):1509-17. PubMed ID: 15563757
    [Abstract] [Full Text] [Related]

  • 4. Optimization of gatifloxacin liposomal hydrogel for enhanced transcorneal permeation.
    Hosny KM.
    J Liposome Res; 2010 Mar 08; 20(1):31-7. PubMed ID: 19545203
    [Abstract] [Full Text] [Related]

  • 5. Probing influence of methodological variation on active loading of acetazolamide into nanoliposomes: biophysical, in vitro, ex vivo, in vivo and rheological investigation.
    Pisal PB, Joshi MA, Padamwar MN, Patil SS, Pokharkar VB.
    Int J Pharm; 2014 Jan 30; 461(1-2):82-8. PubMed ID: 24291077
    [Abstract] [Full Text] [Related]

  • 6. Ciprofloxacin as ocular liposomal hydrogel.
    Hosny KM.
    AAPS PharmSciTech; 2010 Mar 30; 11(1):241-6. PubMed ID: 20151337
    [Abstract] [Full Text] [Related]

  • 7. Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug.
    Naguib SS, Hathout RM, Mansour S.
    Drug Deliv; 2017 Nov 30; 24(1):99-108. PubMed ID: 28155540
    [Abstract] [Full Text] [Related]

  • 8. Effect of formulation design and freeze-drying on properties of fluconazole multilamellar liposomes.
    El-Nesr OH, Yahiya SA, El-Gazayerly ON.
    Saudi Pharm J; 2010 Oct 30; 18(4):217-24. PubMed ID: 23960730
    [Abstract] [Full Text] [Related]

  • 9. Characterization of drug release from liposomal formulations in ocular fluid.
    Jafari MR, Jones AB, Hikal AH, Williamson JS, Wyandt CM.
    Drug Deliv; 1998 Oct 30; 5(4):227-38. PubMed ID: 19569989
    [Abstract] [Full Text] [Related]

  • 10. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.
    Abdelbary G.
    Pharm Dev Technol; 2011 Feb 30; 16(1):44-56. PubMed ID: 20025433
    [Abstract] [Full Text] [Related]

  • 11. Study of ocular drug delivery system using drug-loaded liposomes.
    Jain RL, Shastri JP.
    Int J Pharm Investig; 2011 Jan 30; 1(1):35-41. PubMed ID: 23071918
    [Abstract] [Full Text] [Related]

  • 12. Liposomal diltiazem HCl as ocular drug delivery system for glaucoma.
    Mokhtar Ibrahim M, Tawfique SA, Mahdy MM.
    Drug Dev Ind Pharm; 2014 Jun 30; 40(6):765-73. PubMed ID: 23570512
    [Abstract] [Full Text] [Related]

  • 13. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits.
    Mishra V, Jain NK.
    Int J Pharm; 2014 Jan 30; 461(1-2):380-90. PubMed ID: 24291772
    [Abstract] [Full Text] [Related]

  • 14. The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits.
    Shafaa MW, Sabra NM, Fouad RA.
    Biopharm Drug Dispos; 2011 Dec 30; 32(9):507-17. PubMed ID: 22028305
    [Abstract] [Full Text] [Related]

  • 15. Preparation and evaluation of thermosensitive liposomal hydrogel for enhanced transcorneal permeation of ofloxacin.
    Hosny KM.
    AAPS PharmSciTech; 2009 Dec 30; 10(4):1336-42. PubMed ID: 19902361
    [Abstract] [Full Text] [Related]

  • 16. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
    Singh J, Chhabra G, Pathak K.
    Drug Dev Ind Pharm; 2014 Sep 30; 40(9):1223-32. PubMed ID: 23837522
    [Abstract] [Full Text] [Related]

  • 17. Development of novel topical tranexamic acid liposome formulations.
    Manosroi A, Podjanasoonthon K, Manosroi J.
    Int J Pharm; 2002 Mar 20; 235(1-2):61-70. PubMed ID: 11879740
    [Abstract] [Full Text] [Related]

  • 18. [Effects of liposomes formulation and preparation method on the stability of acyclovir palmitate liposomes].
    Liu H, Tang R, He XX, Zhang Y.
    Yao Xue Xue Bao; 2002 Jul 20; 37(7):563-6. PubMed ID: 12914330
    [Abstract] [Full Text] [Related]

  • 19. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A, Kumar R, Katare OP.
    J Pharm Pharm Sci; 2004 Jul 16; 7(2):252-9. PubMed ID: 15367383
    [Abstract] [Full Text] [Related]

  • 20. Novel Polymeric Nanoparticles Intended for Ophthalmic Administration of Acetazolamide.
    Quinteros DA, Ferreira LM, Schaffazick SR, Palma SD, Allemandi DA, Cruz L.
    J Pharm Sci; 2016 Oct 16; 105(10):3183-3190. PubMed ID: 27519647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.